top of page

RetiSpec Receives Award from Alzheimer's Drug Discovery Foundation (ADDF)

Updated: Jul 16, 2021

Howard Fillit, M.D., Founding Executive Director and Chief Science Officer of ADDF, said, "We believe that RetiSpec's retinal scanner stands out and shows promise as a unique diagnostic tool among a range of technologies in development. The technology has the potential to facilitate early diagnosis, improve the lives of patients and their loved ones and save the healthcare system money and resources. The technology will also be useful in making clinical trials for Alzheimer's disease more efficient."

0 views0 comments


bottom of page